Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jan 9, 2013	powchik peter	Officer	Option Execute	5,752	16.80 - 21.25
Feb 21, 2012	powchik peter	Officer	Option Execute	109,866	15.64 - 21.92
Aug 1, 2011	powchik peter	Officer	Option Execute	15,144	15.64
Jul 25, 2011	powchik peter	Officer	Option Execute	25,000	15.64
Sep 6, 2011	roberts william	Officer	Option Execute	30,000	11.64
Jan 10, 2012	roberts william	Officer	Option Execute	60,000	20.32 - 21.92
Sep 16, 2008	roberts william	Officer	Option Execute	25,000	8.77
Aug 20, 2008	roberts william	Officer	Option Execute	34,840	6.50
Dec 28, 2009	roberts william	Officer	Option Execute	12,500	8.50
Feb 2, 2010	roberts william	Officer	Option Execute	12,000	13.00
Feb 3, 2010	roberts william	Officer	Option Execute	1,500	13.00
Jan 27, 2010	roberts william	Officer	Option Execute	6,500	13.00
Sep 1, 2009	roberts william	Officer	Option Execute	14,166	8.50
Apr 27, 2009	roberts william	Officer	Option Execute	15,160	6.50
Aug 12, 2009	roberts william	Officer	Option Execute	6,666	8.50
Jan 7, 2011	roberts william	Officer	Option Execute	10,000	9.49
Jan 14, 2011	roberts william	Officer	Option Execute	1,188	9.49
Jan 18, 2011	roberts william	Officer	Option Execute	18,812	9.49
Sep 14, 2011	ryan arthur f	Director	Option Execute	115,000	9.17 - 24.41
Dec 16, 2011	schleifer leonard s	Officer	Option Execute	250,000	28.01
Showing 181-200 of 638 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.